Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regression of Liver Fibrosis Assessed by Transient Elastography After Daclatasvir and Asunaprevir Combined Treatment in Advanced Fibrotic/Cirrhotic Patients With Chronic Hepatitis C Genotype 1b Infection

NCT02865369 is registered in ClinicalTrials.gov with Sang Gyune Kim as lead sponsor.

NCT NCT02865369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02865369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regression of Liver Fibrosis Assessed by Transient Elastography After Daclatasvir and Asunaprevir Combined Treatment in Advanced Fibrotic/Cirrhotic Patients With Chronic Hepatitis C Genotype 1b Infection
Lead sponsor
Sang Gyune Kim
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 31, 2022
Enrollment
103 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c